Specific Type Of DNA Likely To Be Target Of Future Cancer Therapies: Yale Study

Specific Type Of DNA Likely To Be Target Of Future Cancer Therapies: Yale Study

2 mins readComment FOLLOW US
Pallavi
Pallavi Pathak
Assistant Manager Content
New Delhi, Updated on Oct 17, 2024 14:59 IST

The researchers have found that people with more aggressive and advanced cancers have a specific type of DNA - ecDNA. It is found more in people who have received treatments for cancer earlier. The new findings can result in making this kind of DNA target for future therapies.

Specific Type Of DNA Likely To Be Target Of Future Cancer Therapies: Yale Study

A study by Yale Cancer Center researchers at Yale School of Medicine has suggested that a specific kind of DNA extrachromosomal or ecDNA can be a target in future cancer therapies. The scientists found the presence of extrachromosomal or ecDNA in higher concentration in people with more aggressive and advanced cancers.

Yale researchers used over 8,000 tumour samples of two types of patients, one whose cancers were recently diagnosed and the other one who earlier received the cancer treatments. They used data available from the Hartwig Medical Foundation, the International Cancer Genomics Consortium, Cancer Genome Atlas, and the Glioma Longitudinal Analysis Consortium.

Yale Study On Cancer Treatment Details

The researchers found that those who were earlier treated with radiation and chemotherapy had higher amounts of ecDNA and this could be a survival advantage for those cancers.

Senior author of the paper, Roel Verhaak, the Harvey and Kate Cushing Professor of Neurosurgery at Yale School of Medicine and member of Yale Cancer Center said, “Our research suggests that ecDNA helps tumours become more aggressive. EcDNA has a distinct mechanism and plays an important role, not just for breast or lung cancer, but across many cancer types.”

In advanced cancer, ecDNA is prone to rapid mutations called "hypermutations" and this is expected to be the main reason why cancer becomes difficult to treat as the disease progresses.

“In the lab, we’re using drug libraries to find out what can specifically target ecDNA-containing cells. We want to find vulnerabilities in tumours that have ecDNA, as ecDNA-targeting therapies could benefit as many as a third of all cancer patients," said Verhaak.








Yale Alumnus Wins 2024 Noble Prize In Economics

James A. Robinson, who received a 2024 Noble Prize In Economics, earned his Ph.D. from Yale University.

“The laureates have shown that one explanation for differences in countries’ prosperity is the societal institutions that were introduced during colonization. Inclusive institutions were often introduced in countries that were poor when they were colonized, over time resulting in a generally prosperous population. This is an important reason for why former colonies that were once rich are now poor, and vice versa," the committee said in announcing this year’s recipients.







About the Author
author-image
Written by
Pallavi Pathak
Assistant Manager Content

With over 11 years of dedicated experience in the field of Study Abroad consulting and writing, Pallavi Pathak stands as a seasoned expert in providing compelling news articles and informative pieces tailored to the... Read Full Bio

Browse universities abroad